Individualized Homeopathic Medicines for Low Back Pain in Lumbar Spondylosis: Double-Blind, Randomized, Placebo-Controlled Trial.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2024;12(14):32 Homeopathy . 2023 Nov;112(4):240-250.What this means for my practice?
The key takeaway from this study is that individualized homeopathic medicines showed some potential for alleviating pain in lumbar spondylosis, particularly in certain pain subscales, but overall, they did not significantly outperform placebo in primary outcome measures. A major limitation of this study is the small sample size and the premature cessation of patient enrollment, which may affect the conclusiveness of the findings.
Study Summary
Forty-nine patients with lumbar spondylosis were randomized to receive either individualized homeopathic medicines (IHMs; n=26) or placebo (n=23). The primary outcome was the Oswestry Disability Index (ODI) for low back pain and disability. Secondary outcomes included the Roland-Morris Disability Questionnaire (RMDQ) and the short form of the McGill Pain Questionnaire (SF-MPQ). Outcomes were assessed monthly for three months. Overall, the results showed no statistically significant differences between the IHMs and placebo groups for the primary outcome. However, some secondary outcomes, such as SF-MPQ subscales, indicated minor benefits for the IHMs group at certain time points. The findings suggest that while IHMs did not significantly outperform placebo in the primary measures, they showed some effect in secondary measures, warranting further research.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
